Lack of association between COPD and transforming growth factor-β1 (TGFB1) genetic polymorphisms in Koreans

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 5, 2006, Pages 504-509

  Yoon, H I ^a   Silverman, E K ^b,c   Lee, H W ^d   Yoo, C G ^d   Lee, C T ^a   Chung, H S ^e   Kim, Y W ^d   Han, S K ^d   Shim, Y S ^d   Yim, Jae Joon ^d,f  

^a Seoul National University Bundang Hospital   (South Korea)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Seoul National University College of Medicine   (South Korea)

^e Seoul National University   (South Korea)

^f Seoul National University Hospital   (South Korea)

Author keywords

Association analysis; Chronic obstructive pulmonary disease; Polymorphism; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EXON; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

CHI-SQUARE DISTRIBUTION; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; LOGISTIC MODELS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33646365923     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ezzati M, Lopez A D. Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362: 847-852.
2. Hoyert D L, Kochanek K D, Murphy S L. Deaths: final data for 1997. Natl Vital Stat Rep 1999; 47: 1-104.
3. Bascom R. Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics 1991; 1: 102-106.
4. O'Brien M L, Buist N R, Murphey W H. Neonatal screening for alpha 1-antitrypsin deficiency. J Pediatr 1978; 92: 1006-1010.
5. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200 000 infants. N Engl J Med 1976; 294: 1316-1321.
6. Smith C A, Harrison D J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350: 630-633.
7. Patuzzo C, Gile L S, Zorzetto M, et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000; 117: 1353-1358.
8. Higham M A, Pride N B, Alikhan A, Morrell N W. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 281-284.
9. Benetazzo M G, Gile L S, Bombieri C, et al. alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. Respir Med 1999; 93: 648-654.
10. Minematsu N, Nakamura H, Iwata M, et al. Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema. Thorax 2003; 58: 623-628.
11. Cheng S L, Yu C J, Chen C J, Yang P C. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 2004; 23: 818-824.
12. Ishii T, Matsuse T, Teramoto S, et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 693-696.
13. Harrison D J, Cantlay A M, Rae F, Lamb D, Smith C A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997; 16: 356-360.
14. Hu R C, Xu Y J, Zhang Z X, Xie J G. [Polymorphism of interleukin-10 gene promoter and its association with susceptibility to chronic obstructive pulmonary disease in Chinese Han people]. [Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003; 20: 504-507.
15. Lu M, Yang B, Cai Y Y. [The relationship between vitamin D binding protein gene polymorphism and chronic obstructive pulmonary disease]. [Chinese]. Zhonghua Nei Ke Za Zhi 2004; 43: 117-120.
16. Ito I, Nagai S, Hoshino Y, et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest 2004; 125: 63-70.
17. Hegab A E, Sakamoto T, Saitoh W, et al. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest 2004; 126: 1832-1839.
18. Hersh C P, Demeo D L, Lange C, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33: 71-78.
19. Teramoto S, Ishii T. No association of tumor necrosis factor-alpha gene polymorphism and copd in Caucasian smokers and Japanese smokers. Chest 2001; 119: 315-316.
20. Ishii T, Matsuse T, Teramoto S, et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med 2000; 94: 847-851.
21. Yim J J, Yoo C G, Lee C T, Kim Y W, Han S K, Shim Y S. Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans. Lung 2002; 180: 119-125.
22. Yim J J, Park G Y, Lee C T, et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000; 55: 121-125.
23. Celedon J C, Lange C, Raby B A, et al. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 2004; 13: 1649-1656.
24. Wu L, Chau J, Young R P, et al. Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59: 126-129.
25. Morris D G, Huang X, Kaminski N, et al. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 2003; 422: 169-173.
26. Pauwels R A, Buist A S, Calverley P M A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
27. Sterner-Kock A, Thorey I S, Koli K, et al. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev 2002; 16: 2264-2273.
28. Takizawa H, Tanaka M, Takami K, et al. Increased expression of transforming growth factor-betal in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001; 163: 1476-1483.
29. de Boer W I, van S A, Sont J K, et al. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1951-1957.
30. Suthanthiram M, Li B, Song J O, et al. Transforminig growth factor-beta1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 2000; 97: 3479-3484.
31. Yamada Y, Miyauchi A, Goto J, et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998; 13: 1569-1576.
32. 1 and prevalence of pulmonary conditions in Japanese-American men. Am Rev Respir Dis 1988; 138: 1398-1404.
33. Purcell S, Cherny S S, Sham P C. Genetic power calculator: design of linkage and association mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.